“The nasal spray did not perform as well in this study as we had hoped,” Sandy Douglas, the chief investigator on the trial at Oxford’s Jenner Institute, says in a university press release. “Delivery ...

The U.S. Food and Drug Administration ( FDA) has approved the use of a nasal spray as a standalone treatment for major depressive disorder, offering a new option for those struggling with ...

The expanded indication allows esketamine nasal spray to be used as a standalone treatment in adults with MDD who have not ...